Bangkok Dusit Medical Services Public Company Limited
Bangkok Dusit Medical Services Public Company Limited (BDUUY) Financial Performance & Income Statement Overview
Explore the financials of Bangkok Dusit Medical Services Public Company Limited (BDUUY), including yearly and quarterly data on income, cash flow, and balance sheets.
Bangkok Dusit Medical Services Public Company Limited (BDUUY) Income Statement & Financial Overview
Explore comprehensive income reports for Bangkok Dusit Medical Services Public Company Limited BDUUY, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $28.08B | $27.40B | $28.15B | $25.70B |
| Cost of Revenue | $17.69B | $17.04B | $17.63B | $16.66B |
| Gross Profit | $10.40B | $10.37B | $10.52B | $9.04B |
| Gross Profit Ratio | $0.37 | $0.38 | $0.37 | $0.35 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $5.15B | $5.48B | $5.31B | $5.15B |
| Operating Expenses | $4.77B | $5.04B | $4.91B | $4.77B |
| Total Costs & Expenses | $22.83B | $22.50B | $22.93B | $21.81B |
| Interest Income | $31.40M | $39.02M | $40.17M | $47.46M |
| Interest Expense | $97.12M | $107.87M | $102.42M | $110.56M |
| Depreciation & Amortization | $1.62B | $1.60B | $1.55B | $1.50B |
| EBITDA | $7.30B | $6.99B | $7.22B | $5.82B |
| EBITDA Ratio | $0.26 | $0.26 | $0.26 | $0.23 |
| Operating Income | $5.62B | $5.32B | $5.61B | $4.27B |
| Operating Income Ratio | $0.20 | $0.19 | $0.20 | $0.17 |
| Other Income/Expenses (Net) | -$47.13M | -$43.68M | -$38.33M | -$49.05M |
| Income Before Tax | $5.58B | $5.28B | $5.57B | $4.22B |
| Income Before Tax Ratio | $0.20 | $0.19 | $0.20 | $0.16 |
| Income Tax Expense | $1.08B | $840.60M | $1.15B | $756.08M |
| Net Income | $4.35B | $4.33B | $4.25B | $3.33B |
| Net Income Ratio | $0.15 | $0.16 | $0.15 | $0.13 |
| EPS | $0.27 | $0.27 | $0.27 | $0.21 |
| Diluted EPS | $0.27 | $0.27 | $0.27 | $0.21 |
| Weighted Avg Shares Outstanding | $15.89B | $15.89B | $15.89B | $15.89B |
| Weighted Avg Shares Outstanding (Diluted) | $15.89B | $15.89B | $15.89B | $15.89B |
Over the last four quarters, Bangkok Dusit Medical Services Public Company Limited achieved steady financial progress, growing revenue from $25.70B in Q2 2024 to $28.08B in Q1 2025. Gross profit stayed firm with margins at 37% in Q1 2025 versus 35% in Q2 2024. Operating income totaled $5.62B in Q1 2025, maintaining a 20% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $7.30B. Net income rose to $4.35B, with EPS at $0.27. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan